sample_name,protocol,organism,read_type,data_source,srr,srx,sample_title,sample_geo_accession,sample_status,sample_submission_date,sample_last_update_date,sample_type,sample_channel_count,sample_source_name_ch1,sample_organism_ch1,sample_taxid_ch1,sample_treatment_protocol_ch1,sample_growth_protocol_ch1,sample_molecule_ch1,sample_label_ch1,sample_description,sample_platform_id,sample_contact_name,sample_contact_institute,sample_contact_address,sample_contact_city,sample_contact_zip_postal_code,sample_contact_country,sample_supplementary_file,sample_series_id,sample_data_row_count,id_ref,value,big_key,tissue,gender,population
normal_ba27apr05,,,,,,,Normal_BA27apr05,GSM1465192,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465192/suppl/GSM1465192_miR_252182711931_S01_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465192,normal prostate,male,Caucasian
normal_fi01giu05,,,,,,,Normal_FI01giu05,GSM1465193,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465193/suppl/GSM1465193_miR_252182711931_S01_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465193,normal prostate,male,Caucasian
normal_ga25mag05,,,,,,,Normal_GA25mag05,GSM1465194,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465194/suppl/GSM1465194_miR_252182711931_S01_miRNA-v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465194,normal prostate,male,Caucasian
normal_vg25mag05,,,,,,,Normal_VG25mag05,GSM1465195,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465195/suppl/GSM1465195_miR_252182711931_S01_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465195,normal prostate,male,Caucasian
normal_t10,,,,,,,Normal_T10,GSM1465196,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465196/suppl/GSM1465196_US22502614_252182713983_S02_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465196,normal prostate,male,Caucasian
normal_t63,,,,,,,Normal_T63,GSM1465197,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465197/suppl/GSM1465197_US22502614_252182713983_S02_miRNA-v1_95_May07_1_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465197,normal prostate,male,Caucasian
normal_t66,,,,,,,Normal_T66,GSM1465198,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465198/suppl/GSM1465198_US22502614_252182713983_S02_miRNA-v1_95_May07_1_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465198,normal prostate,male,Caucasian
normal_t189,,,,,,,Normal_T189,GSM1465199,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465199/suppl/GSM1465199_US22502614_252182713983_S02_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465199,normal prostate,male,Caucasian
normal_t190,,,,,,,Normal_T190,GSM1465200,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465200/suppl/GSM1465200_US22502614_252182713983_S02_miRNA-v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465200,normal prostate,male,Caucasian
normal_t202,,,,,,,Normal_T202,GSM1465201,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465201/suppl/GSM1465201_US22502614_252182713983_S02_miRNA-v1_95_May07_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465201,normal prostate,male,Caucasian
normal_t229,,,,,,,Normal_T229,GSM1465202,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465202/suppl/GSM1465202_US22502614_252182713983_S02_miRNA-v1_95_May07_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465202,normal prostate,male,Caucasian
normal_t323,,,,,,,Normal_T323,GSM1465203,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465203/suppl/GSM1465203_US22502614_252182713983_S02_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465203,normal prostate,male,Caucasian
normal_tl28apr05,,,,,,,Normal_TL28apr05,GSM1465204,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465204/suppl/GSM1465204_US22502614_252182713984_S01_miRNA_107_Sep09_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465204,normal prostate,male,Caucasian
normal_rf128apr05,,,,,,,Normal_RF128apr05,GSM1465205,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465205/suppl/GSM1465205_US22502614_252182713984_S01_miRNA_107_Sep09_1_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465205,normal prostate,male,Caucasian
normal_cm17mag05,,,,,,,Normal_CM17mag05,GSM1465206,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465206/suppl/GSM1465206_US22502614_252182713984_S01_miRNA_107_Sep09_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465206,normal prostate,male,Caucasian
normal_cg04mag05,,,,,,,Normal_CG04mag05,GSM1465207,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465207/suppl/GSM1465207_US22502614_252182713984_S01_miRNA_107_Sep09_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465207,normal prostate,male,Caucasian
normal_t319,,,,,,,Normal_T319,GSM1465208,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465208/suppl/GSM1465208_US22502614_252182713984_S01_miRNA_107_Sep09_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465208,normal prostate,male,Caucasian
normal_t337,,,,,,,Normal_T337,GSM1465209,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465209/suppl/GSM1465209_US22502614_252182714390_S01_miRNA_107_Sep09_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465209,normal prostate,male,Caucasian
normal_t188,,,,,,,Normal_T188,GSM1465210,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465210/suppl/GSM1465210_US22502614_252182714390_S01_miRNA_107_Sep09_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465210,normal prostate,male,Caucasian
normal_t218,,,,,,,Normal_T218,GSM1465211,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465211/suppl/GSM1465211_US22502614_252182714390_S01_miRNA_107_Sep09_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465211,normal prostate,male,Caucasian
normal_t114,,,,,,,Normal_T114,GSM1465212,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Normal prostate,Homo sapiens,9606,NA,NA,total RNA,Cy3,Peripheral region of the prostate from Caucasian men without PCa.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465212/suppl/GSM1465212_US22502614_252182714390_S01_miRNA_107_Sep09_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465212,normal prostate,male,Caucasian
pca_a2,,,,,,,PCa_A2,GSM1465213,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465213/suppl/GSM1465213_Bergamaschi_252182711579_S01_miRNA-v1_95_May07_1_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465213,prostate adenocarcinoma,male,Caucasian
pca_a3,,,,,,,PCa_A3,GSM1465214,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465214/suppl/GSM1465214_Bergamaschi_252182711579_S01_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465214,prostate adenocarcinoma,male,Caucasian
pca_a5,,,,,,,PCa_A5,GSM1465215,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465215/suppl/GSM1465215_Bergamaschi_252182711579_S01_miRNA_v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465215,prostate adenocarcinoma,male,Caucasian
pca_a9,,,,,,,PCa_A9,GSM1465216,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465216/suppl/GSM1465216_Bergamaschi_252182711579_S01_miRNA-v1_95_May07_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465216,prostate adenocarcinoma,male,Caucasian
pca_aa62,,,,,,,PCa_AA62,GSM1465217,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465217/suppl/GSM1465217_Bergamaschi_252182711579_S01_miRNA-v1_95_May07_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465217,prostate adenocarcinoma,male,Caucasian
pca_aa65,,,,,,,PCa_AA65,GSM1465218,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465218/suppl/GSM1465218_Bergamaschi_252182711579_S01_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465218,prostate adenocarcinoma,male,Caucasian
pca_cc83,,,,,,,PCa_CC83,GSM1465219,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465219/suppl/GSM1465219_miR_Bergamaschi-PCa_252182711938_S01_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465219,prostate adenocarcinoma,male,Caucasian
pca_d37,,,,,,,PCa_D37,GSM1465220,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465220/suppl/GSM1465220_miR_Bergamaschi-PCa_252182711938_S01_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465220,prostate adenocarcinoma,male,Caucasian
pca_d40,,,,,,,PCa_D40,GSM1465221,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465221/suppl/GSM1465221_miR_Bergamaschi-PCa_252182711938_S01_miRNA-v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465221,prostate adenocarcinoma,male,Caucasian
pca_e45,,,,,,,PCa_E45,GSM1465222,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465222/suppl/GSM1465222_miR_Bergamaschi-PCa_252182711938_S01_miRNA-v1_95_May07_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465222,prostate adenocarcinoma,male,Caucasian
pca_cc87,,,,,,,PCa_CC87,GSM1465223,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465223/suppl/GSM1465223_miR_Bergamaschi-PCa_252182711938_S01_miRNA-v1_95_May07_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465223,prostate adenocarcinoma,male,Caucasian
pca_cc91,,,,,,,PCa_CC91,GSM1465224,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465224/suppl/GSM1465224_miR_Bergamaschi-PCa_252182711938_S01_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465224,prostate adenocarcinoma,male,Caucasian
pca_aa69,,,,,,,PCa_AA69,GSM1465225,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465225/suppl/GSM1465225_miR-PCa_252182711580_S01_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465225,prostate adenocarcinoma,male,Caucasian
pca_aa90,,,,,,,PCa_AA90,GSM1465226,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465226/suppl/GSM1465226_miR-PCa_252182711580_S01_miRNA-v1_95_May07_1_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465226,prostate adenocarcinoma,male,Caucasian
pca_aa97,,,,,,,PCa_AA97,GSM1465227,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465227/suppl/GSM1465227_miR-PCa_252182711580_S01_miRNA-v1_95_May07_1_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465227,prostate adenocarcinoma,male,Caucasian
pca_b11,,,,,,,PCa_B11,GSM1465228,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465228/suppl/GSM1465228_miR-PCa_252182711580_S01_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465228,prostate adenocarcinoma,male,Caucasian
pca_b12,,,,,,,PCa_B12,GSM1465229,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465229/suppl/GSM1465229_miR-PCa_252182711580_S01_miRNA-v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465229,prostate adenocarcinoma,male,Caucasian
pca_b17,,,,,,,PCa_B17,GSM1465230,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465230/suppl/GSM1465230_miR-PCa_252182711580_S01_miRNA-v1_95_May07_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465230,prostate adenocarcinoma,male,Caucasian
pca_bb5,,,,,,,PCa_BB5,GSM1465231,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465231/suppl/GSM1465231_miR-PCa_252182711580_S01_miRNA-v1_95_May07_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465231,prostate adenocarcinoma,male,Caucasian
pca_c25,,,,,,,PCa_C25,GSM1465232,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465232/suppl/GSM1465232_miR-PCa_252182711580_S01_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465232,prostate adenocarcinoma,male,Caucasian
pca_c27,,,,,,,PCa_C27,GSM1465233,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465233/suppl/GSM1465233_miR-PCa_252182711581_S01_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465233,prostate adenocarcinoma,male,Caucasian
pca_cc17,,,,,,,PCa_CC17,GSM1465234,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465234/suppl/GSM1465234_miR-PCa_252182711581_S01_miRNA-v1_95_May07_1_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465234,prostate adenocarcinoma,male,Caucasian
pca_cc3,,,,,,,PCa_CC3,GSM1465235,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465235/suppl/GSM1465235_miR-PCa_252182711581_S01_miRNA-v1_95_May07_1_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465235,prostate adenocarcinoma,male,Caucasian
pca_cc35,,,,,,,PCa_CC35,GSM1465236,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465236/suppl/GSM1465236_miR-PCa_252182711581_S01_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465236,prostate adenocarcinoma,male,Caucasian
pca_cc41,,,,,,,PCa_CC41,GSM1465237,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465237/suppl/GSM1465237_miR-PCa_252182711581_S01_miRNA-v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465237,prostate adenocarcinoma,male,Caucasian
pca_cc62,,,,,,,PCa_CC62,GSM1465238,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465238/suppl/GSM1465238_miR-PCa_252182711581_S01_miRNA-v1_95_May07_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465238,prostate adenocarcinoma,male,Caucasian
pca_cc75,,,,,,,PCa_CC75,GSM1465239,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465239/suppl/GSM1465239_miR-PCa_252182711581_S01_miRNA-v1_95_May07_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465239,prostate adenocarcinoma,male,Caucasian
pca_cc8,,,,,,,PCa_CC8,GSM1465240,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465240/suppl/GSM1465240_miR-PCa_252182711581_S01_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465240,prostate adenocarcinoma,male,Caucasian
pca_p60,,,,,,,PCa_P60,GSM1465241,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465241/suppl/GSM1465241_miR-PCa_252182711929_S01_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465241,prostate adenocarcinoma,male,Caucasian
pca_q65,,,,,,,PCa_Q65,GSM1465242,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465242/suppl/GSM1465242_miR-PCa_252182711929_S01_miRNA-v1_95_May07_1_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465242,prostate adenocarcinoma,male,Caucasian
pca_q70,,,,,,,PCa_Q70,GSM1465243,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465243/suppl/GSM1465243_miR-PCa_252182711929_S01_miRNA-v1_95_May07_1_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465243,prostate adenocarcinoma,male,Caucasian
pca_v18,,,,,,,PCa_V18,GSM1465244,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465244/suppl/GSM1465244_miR-PCa_252182711929_S01_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465244,prostate adenocarcinoma,male,Caucasian
pca_w25,,,,,,,PCa_W25,GSM1465245,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465245/suppl/GSM1465245_miR-PCa_252182711929_S01_miRNA-v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465245,prostate adenocarcinoma,male,Caucasian
pca_w28,,,,,,,PCa_W28,GSM1465246,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465246/suppl/GSM1465246_miR-PCa_252182711929_S01_miRNA-v1_95_May07_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465246,prostate adenocarcinoma,male,Caucasian
pca_x40,,,,,,,PCa_X40,GSM1465247,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465247/suppl/GSM1465247_miR-PCa_252182711929_S01_miRNA-v1_95_May07_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465247,prostate adenocarcinoma,male,Caucasian
pca_y44,,,,,,,PCa_Y44,GSM1465248,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465248/suppl/GSM1465248_miR-PCa_252182711929_S01_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465248,prostate adenocarcinoma,male,Caucasian
pca_f51,,,,,,,PCa_F51,GSM1465249,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465249/suppl/GSM1465249_miR-PCa_252182711939_S02_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465249,prostate adenocarcinoma,male,Caucasian
pca_f55,,,,,,,PCa_F55,GSM1465250,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465250/suppl/GSM1465250_miR-PCa_252182711939_S02_miRNA-v1_95_May07_1_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465250,prostate adenocarcinoma,male,Caucasian
pca_g65,,,,,,,PCa_G65,GSM1465251,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465251/suppl/GSM1465251_miR-PCa_252182711939_S02_miRNA-v1_95_May07_1_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465251,prostate adenocarcinoma,male,Caucasian
pca_g70,,,,,,,PCa_G70,GSM1465252,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465252/suppl/GSM1465252_miR-PCa_252182711939_S02_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465252,prostate adenocarcinoma,male,Caucasian
pca_h75,,,,,,,PCa_H75,GSM1465253,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465253/suppl/GSM1465253_miR-PCa_252182711939_S02_miRNA-v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465253,prostate adenocarcinoma,male,Caucasian
pca_k6,,,,,,,PCa_K6,GSM1465254,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465254/suppl/GSM1465254_miR-PCa_252182711939_S02_miRNA-v1_95_May07_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465254,prostate adenocarcinoma,male,Caucasian
pca_l12,,,,,,,PCa_L12,GSM1465255,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465255/suppl/GSM1465255_miR-PCa_252182711939_S02_miRNA-v1_95_May07_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465255,prostate adenocarcinoma,male,Caucasian
pca_l16,,,,,,,PCa_L16,GSM1465256,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465256/suppl/GSM1465256_miR-PCa_252182711939_S02_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465256,prostate adenocarcinoma,male,Caucasian
pca_m21,,,,,,,PCa_M21,GSM1465257,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465257/suppl/GSM1465257_miR-PCa_252182711940_S01_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465257,prostate adenocarcinoma,male,Caucasian
pca_m26,,,,,,,PCa_M26,GSM1465258,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465258/suppl/GSM1465258_miR-PCa_252182711940_S01_miRNA-v1_95_May07_1_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465258,prostate adenocarcinoma,male,Caucasian
pca_n34,,,,,,,PCa_N34,GSM1465259,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465259/suppl/GSM1465259_miR-PCa_252182711940_S01_miRNA-v1_95_May07_1_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465259,prostate adenocarcinoma,male,Caucasian
pca_o47,,,,,,,PCa_O47,GSM1465260,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465260/suppl/GSM1465260_miR-PCa_252182711940_S01_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465260,prostate adenocarcinoma,male,Caucasian
pca_p53,,,,,,,PCa_P53,GSM1465261,Public on Mar 09 2017,Aug 05 2014,Mar 09 2017,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465261/suppl/GSM1465261_miR-PCa_252182711940_S01_miRNA-v1_95_May07_2_2.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465261,prostate adenocarcinoma,male,Caucasian
pca_p55,,,,,,,PCa_P55,GSM1465262,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465262/suppl/GSM1465262_miR-PCa_252182711940_S01_miRNA-v1_95_May07_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465262,prostate adenocarcinoma,male,Caucasian
pca_p57,,,,,,,PCa_P57,GSM1465263,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465263/suppl/GSM1465263_miR-PCa_252182711940_S01_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465263,prostate adenocarcinoma,male,Caucasian
pca_y48,,,,,,,PCa_Y48,GSM1465264,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465264/suppl/GSM1465264_miRPCa-Pina_252182711930_S01_miRNA-v1_95_May07_1_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465264,prostate adenocarcinoma,male,Caucasian
pca_y50,,,,,,,PCa_Y50,GSM1465265,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465265/suppl/GSM1465265_miRPCa-Pina_252182711930_S01_miRNA-v1_95_May07_1_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465265,prostate adenocarcinoma,male,Caucasian
pca_z55,,,,,,,PCa_Z55,GSM1465266,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465266/suppl/GSM1465266_miRPCa-Pina_252182711930_S01_miRNA-v1_95_May07_2_1.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465266,prostate adenocarcinoma,male,Caucasian
pca_z56,,,,,,,PCa_Z56,GSM1465267,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465267/suppl/GSM1465267_miRPCa-Pina_252182711930_S01_miRNA-v1_95_May07_2_4.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465267,prostate adenocarcinoma,male,Caucasian
pca_z59,,,,,,,PCa_Z59,GSM1465268,Public on Mar 09 2017,Aug 05 2014,Dec 18 2019,RNA,1,Prostate cancer,Homo sapiens,9606,NA,NA,total RNA,Cy3,Prostate adenocarcinoma from Caucasian men.,GPL13264,"Paola,,Ostano",Fondazione Edo ed Elvo Tempia,via Malta 3,Biella,13900,Italy,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1465nnn/GSM1465268/suppl/GSM1465268_US22502614_252182713984_S01_miRNA_107_Sep09_2_3.txt.gz,"GSE60117, GSE60371",2689,,Log2 normalized intensity value,GSM1465268,prostate adenocarcinoma,male,Caucasian
